Clinical Trial Update: Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating GSK1358820 for post-stroke upper limb spasticity has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Spasticity
• Stroke

Drugs mentioned

• GSK1358820

Snippet

Sponsor: GlaxoSmithKline | Conditions: Post-Stroke Spasticity, Cerebrovascular Accident | Phase 3 | Status: COMPLETED | Results posted: 2010-02-10